Ophthalmology Times: November 1, 2020

Novel OCT system with AI-based image analysis holds promise.

With several clinical trials underway, ocular therapy is seen as having potential in the treatment of a number of gene-related diseases.

Improvements gained prior to surgery can result in positive outcomes.

Protocol T Extension Study details methods needed to maintain VA gains over time.

Interim data from a cross-sectional study raise concerns that repeated intravitreal injections of an anti-VEGF agent may be associated with a decline in cognitive health.

Newest advances improving ophthalmologists’ performance in operating room.

Working as an investigator can prove to be a positive experience for physicians

Consistent message, top-of-mind awareness are strategies for growth.

Pandemic is driving — and accelerating — changes in how ophthalmic care is delivered to patients.

A word from Chief Medical Editor Peter J. McDonnell, MD.

Study shows improvements in signs, symptoms after 3 months of treatment

Check out the latest cartoon!

The year 2020 dished up a November surprise with a tie between Bascom Palmer Eye Institute and the Wilmer Eye Institute at the top of the rankings for Best Overall Program in the Ophthalmology Times® Best Program Survey.